Endoscopic Sleeve Gastroplasty (ESG) for High-Risk Patients, High Body Mass Index (> 50 kg/m2) Patients, and Contraindication to Abdominal Surgery.

Renjie LiWilfried Veltzke-SchliekerAndreas AdlerMaximilian SpechtWael EskanderMahmoud IsmailHarun BadakhshiManoel Passos GalvaoRicardo Zorron

Published in: Obesity surgery (2021)

ESG can be used as a safe, feasible, and effective option for the therapy of patients with superobesity, high-risk patients, and patients contraindicated to abdominal surgery. Graphical Abstract.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
body mass index
newly diagnosed
peritoneal dialysis
prognostic factors
stem cells
physical activity
cell therapy
smoking cessation